Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RS | NUE |
|---|---|---|
| Price | $389.09 | $233.60 |
| Change today | ▲ 1.13% | ▼ 0.06% |
| Market cap | $19.86B | $53.00B |
| Return, 3 months | +4.8% | +6.7% |
| Return, year to date | +36.1% | +44.1% |
| Return, 1 year | +39.5% | +74.1% |
| P/E (TTM) | 22.6 | 18.6 |
| P/B | 2.7 | 2.4 |
| P/E percentile vs own 5y | 86th | 76th |
| Dividend yield | 1.26% | 0.95% |
| Revenue growth (YoY, latest qtr) | +26.5% | +23.0% |
| Net profit growth (YoY) | +38.2% | +81.3% |
| Gross margin | 28.2% | 15.5% |
| Operating margin | 7.8% | 11.5% |
| Net margin | 5.7% | 8.0% |
| Return on equity | 12.2% | 13.5% |
| Analyst target vs. price | +5.6% | +22.9% |
| Analyst buy share | 25% | 70% |
| RSI (14) | 44 | 37 |
| 30-day volatility | 29.3% | 36.8% |
| Max drawdown, 1 year | -19.0% | -18.4% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
